Sign in
4

Changes in Ownership

HALOZYME THERAPEUTICS, INC. Filed Acc 0001179110-21-009169

President and CEO sold 50,000 shares at an average $40.09 ($2,004,390)

  • President and CEO acquired 50,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Torley Helen · President and CEO

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2021-10-04 Exercise or conversion : show line 1 in the form +50,000 $14.66 $733,000 587,160 D
2021-10-04 Sale : show line 2 in the form −44,143 $39.97 $1,764,528 543,017 D
2021-10-04 Sale : show line 3 in the form −5,857 $40.95 $239,862 537,160 D
Open-market sales · 50,000 sh · avg $40.09 · $2,004,390

Table II: Derivative

1 line
Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
2021-10-04 Exercise or conversion : show line 4 in the form Option to Purchase Common Stock −50,000 $14.66 $733,000 $14.66 2024-01-06 50,000 200,000 D
Loading xslF345X03/edgar.xml…